Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 26, 2024.
All times in Eastern Daylight Time.
-
Domo to Participate in the TD Cowen 52nd Annual Technology, Media & Telecom ConferenceSILICON SLOPES, Utah--(BUSINESS WIRE)--Today Domo (Nasdaq: DOMO) announced that its Founder and CEO Josh James will present at the TD Cowen 52nd Annual Technology, Media & Telecom Conference on... more »
-
Bentley Systems, Incorporated Declares Second Quarter 2024 DividendEXTON, Pa.--(BUSINESS WIRE)--Bentley Systems, Incorporated Declares Second Quarter 2024 Dividend more »
-
TriCo Bancshares Announces Quarterly Cash DividendCHICO, Calif.--(BUSINESS WIRE)--The Board of Directors of TriCo Bancshares (NASDAQ: TCBK) (the “Company”), parent company of Tri Counties Bank, declared a quarterly cash dividend of $0.33 (thirty-t... more »
-
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Direct Digital Holdings, Inc. (DRCT) InvestorsNEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Texas on behalf of those ... more »
-
iHealthScreen Developed and Validated Risk Prediction Models for Cardiovascular Diseases Using Individual’s Retinal Color Images and Health DataNEW YORK--(BUSINESS WIRE)--iPredict™ Stroke and heart attack prediction models provide AI-based automated prediction scores for incident stroke and heart attack (i.e., myocardial infarction (MI)) w... more »
-
Migliaccio & Rathod Investigates Trionfo Solutions, LLC Data BreachWASHINGTON--(BUSINESS WIRE)--Migliaccio & Rathod LLP is actively investigating the Trionfo Solutions, LLC (“Trionfo”). This breach has affected 65,787 individuals and their personal information... more »
-
CHICAGO--(BUSINESS WIRE)--ComEd today joined leaders from the U.S. Department of Energy (DOE), the City of Chicago and the community of Bronzeville to mark the completion of the Bronzeville Communi... more »
-
Riassunto: SLB OneSubsea si aggiudica il contratto per la fase 3, stadio 2 del progetto Troll di Equinor nel Mare del NordHOUSTON--(BUSINESS WIRE)--Notizie normative: SLB (NYSE: SLB) ha annunciato l'assegnazione di un importante contratto da parte di Equinor alla sua joint venture OneSubsea™. L'aggiudicazione sfrutta ... more »
-
TVS Motor lance la TVS HLX 125 à 5 vitesses en TanzanieDAR ES SALAM, Tanzanie--(BUSINESS WIRE)--TVS Motor Company (TVSM), l'un des principaux constructeurs automobiles mondiaux dans les segments des deux et trois roues, annonce aujourd'hui le lancement... more »
-
Cameco finalise un placement de débentures de 500 millions de dollarsSASKATOON, Saskatchewan--(BUSINESS WIRE)--Cameco (TSX : CCO ; NYSE : CCJ) annonce aujourd'hui avoir finalisé son placement privé de débentures (le « placement ») précédemment annoncé, consistant en... more »
-
Europäische Arzneimittel-Agentur (EMA) validiert Einreichungen von Henlius und Organon für den Prolia ® und Xgeva ® (Denosumab) Biosimilar-Kandidaten HLX14SHANGHAI (China) und JERSEY CITY (New Jersey)--(BUSINESS WIRE)--Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) gaben heute bekannt, dass die Europäische Arzneimittel-Agentur (EMA)... more »
-
L’Agence européenne des médicaments (EMA) entérine les dépôts de Henlius et d’Organon pour le candidat biosimilaire HLX14 de Prolia ® et Xgeva ® (denosumab)SHANGHAI, Chine et JERSEY CITY, New Jersey--(BUSINESS WIRE)--Shanghai Henlius Biotech, Inc. (2696.HK) et Organon (NYSE : OGN) ont annoncé aujourd’hui que l’Agence européenne des médicaments (EMA) a... more »
-
Riassunto: L'Agenzia Europea dei Medicinali (EMA) convalida le domande di Henlius e Organon per HLX14, candidato biosimilare di Prolia ® e Xgeva ® (denosumab)SHANGHAI, Cina e JERSEY CITY, N.J.--(BUSINESS WIRE)--Shanghai Henlius Biotech, Inc. (2696.HK) e Organon (NYSE: OGN) oggi hanno annunciato che l'Agenzia europea per i medicinali (EMA, European Medic... more »
-
Agência Europeia de Medicamentos (EMA) valida os registros da Henlius e da Organon para o HLX14, candidato biossimilar do Prolia ® e do Xgeva ® (denosumabe)XANGAI, China e JERSEY CITY, Nova Jersey--(BUSINESS WIRE)--A Shanghai Henlius Biotech, Inc. (2696.HK) e a Organon (NYSE: OGN) anunciaram hoje que a Agência Europeia de Medicamentos (EMA) validou os... more »
-
Feinstein Academy of Scholars Symposium and Elmezzi Graduate School Commencement draws top scientific minds: Peter J. Hotez, Robert S. Langer, othersMANHASSET, N.Y.--(BUSINESS WIRE)--Many of the nation’s leading physician-scientists came together for two special events hosted by The Feinstein Institutes for Medical Research. On May 22, the Fein... more »